JPS4919020A - - Google Patents

Info

Publication number
JPS4919020A
JPS4919020A JP47058082A JP5808272A JPS4919020A JP S4919020 A JPS4919020 A JP S4919020A JP 47058082 A JP47058082 A JP 47058082A JP 5808272 A JP5808272 A JP 5808272A JP S4919020 A JPS4919020 A JP S4919020A
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP47058082A
Other versions
JPS5119018B2 (ja
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Priority to JP47058082A priority Critical patent/JPS5119018B2/ja
Priority to DE2328579A priority patent/DE2328579A1/de
Priority to AU56597/73A priority patent/AU5659773A/en
Priority to FR7321141A priority patent/FR2201877A1/fr
Publication of JPS4919020A publication Critical patent/JPS4919020A/ja
Publication of JPS5119018B2 publication Critical patent/JPS5119018B2/ja
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A61K39/25—Varicella-zoster virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16734—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16711—Varicellovirus, e.g. human herpesvirus 3, Varicella Zoster, pseudorabies
    • C12N2710/16761—Methods of inactivation or attenuation
    • C12N2710/16764—Methods of inactivation or attenuation by serial passage

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Zoology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Mycology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
JP47058082A 1972-06-10 1972-06-10 Expired JPS5119018B2 (ja)

Priority Applications (4)

Application Number Priority Date Filing Date Title
JP47058082A JPS5119018B2 (ja) 1972-06-10 1972-06-10
DE2328579A DE2328579A1 (de) 1972-06-10 1973-06-05 Varicella-vaccine
AU56597/73A AU5659773A (en) 1972-06-10 1973-06-06 Live varicella vaccines
FR7321141A FR2201877A1 (en) 1972-06-10 1973-06-08 Live varicella vaccine - produced using rabbit kidney cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP47058082A JPS5119018B2 (ja) 1972-06-10 1972-06-10

Publications (2)

Publication Number Publication Date
JPS4919020A true JPS4919020A (ja) 1974-02-20
JPS5119018B2 JPS5119018B2 (ja) 1976-06-14

Family

ID=13073982

Family Applications (1)

Application Number Title Priority Date Filing Date
JP47058082A Expired JPS5119018B2 (ja) 1972-06-10 1972-06-10

Country Status (4)

Country Link
JP (1) JPS5119018B2 (ja)
AU (1) AU5659773A (ja)
DE (1) DE2328579A1 (ja)
FR (1) FR2201877A1 (ja)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4953771A (ja) * 1972-09-27 1974-05-24
JPS51128778U (ja) * 1975-03-25 1976-10-18

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5324526U (ja) * 1976-08-09 1978-03-02
GB2077590A (en) * 1980-01-25 1981-12-23 Wistar Inst Highly attenuated varicella virus vaccine and production thereof
US4315914A (en) * 1980-04-04 1982-02-16 Seiji Arakawa Pharmaceutical compositions useful as cellular immunopotentiator and antitumor agent and process for production thereof

Cited By (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS4953771A (ja) * 1972-09-27 1974-05-24
JPS5342231B2 (ja) * 1972-09-27 1978-11-09
JPS51128778U (ja) * 1975-03-25 1976-10-18
JPS563157Y2 (ja) * 1975-03-25 1981-01-23

Also Published As

Publication number Publication date
FR2201877A1 (en) 1974-05-03
JPS5119018B2 (ja) 1976-06-14
AU5659773A (en) 1974-12-12
DE2328579A1 (de) 1974-01-17

Similar Documents

Publication Publication Date Title
JPS5411822Y2 (ja)
JPS4924057A (ja)
JPS5119018B2 (ja)
JPS539492B2 (ja)
JPS4963022A (ja)
JPS5342231B2 (ja)
JPS53920B2 (ja)
JPS5344665B2 (ja)
JPS4950658A (ja)
JPS4956461A (ja)
CS154134B1 (ja)
JPS4997976U (ja)
CS152691B1 (ja)
CS152699B1 (ja)
JPS4883271A (ja)
CS152731B1 (ja)
CS158014B1 (ja)
CH762773A4 (ja)
CH577010A5 (ja)
BG19349A1 (ja)
CH589011A5 (ja)
CH812573A4 (ja)
CH578290A5 (ja)
CH608780A5 (ja)
CH605317A5 (ja)